4th Gamma Delta T Therapies Summit
The 4th Gamma Delta T Therapies Summit returns to Boston this July as the most comprehensive, discovery-to-clinical delivery, gamma delta-dedicated summit.
Spurred by early evidence of clinical efficacy, the industry returns in 2023 armed with more subset-specific and clinical mechanistic understanding, snowballing investment, and growing expert end-to-end teams.
Join 40+ industry-leading speakers from the likes of Adicet Bio, Leucid, Century Therapeutics, Imcheck Therapeutics, IN8bio, Sanofi, and Takeda across two pre-conference days and two dedicated tracks of content designed to maximize your clinical and product optimization, and research and translational development.
If you are looking for ways to contrast subsets, characterize mechanisms of action, and optimize product design to enhance your gamma delta clinical pipeline and develop globally accessible solid tumor therapies, then this year’s event is not to be missed.
